PCAD (Pharmaceutical Consultation At Discharge)
- Conditions
- Drug related problems (medicijn gerelateerde problemen)
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 720
Inclusion Criteria
1. Patients at the department of internal medicine who are prescribed at least one medication.
Exclusion Criteria
1. No informed consent given
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Re-hospitalisations after six months will be the primary outcome measure.
- Secondary Outcome Measures
Name Time Method - interventions registered during the PCAD project (medication errors, quality of pharmacotherapy etc.)<br /><br>- compliance, change in attitude about medication, satisfaction with medication information<br /><br>- costs, quality of life<br />
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie drug-related problems in multicultural internal medicine populations?
How does pharmaceutical consultation at discharge compare to standard discharge practices in reducing readmissions for drug-related issues?
Are there specific biomarkers that identify patients at high risk for post-discharge medication errors in the PCAD trial?
What adverse events are commonly associated with medication management transitions in hospitalized patients?
What drug classes or combination therapies show promise in addressing pharmacotherapy challenges in diverse patient cohorts?